All Outputs (2)

Real-world effectiveness of methotrexate, ciclosporin, acitretin and fumaric acid esters for psoriasis: Does treatment history matter? (2019)
Presentation / Conference
Mason, K. J. (2019, August). Real-world effectiveness of methotrexate, ciclosporin, acitretin and fumaric acid esters for psoriasis: Does treatment history matter?. Poster presented at 35th International Conference on Pharmacoepidemiology & Therapeutic Risk Management, Pennsylvania Convention Center, Philadelphia, PA, USA

Background: Real-world effectiveness of the systemic therapies methotrexate (MTX), ciclosporin (CsA), acitretin (ACI) and fumaric acid esters (FAE) prescribed to patients with moderate–severe psoriasis is poorly characterized. Objectives: To deter... Read More about Real-world effectiveness of methotrexate, ciclosporin, acitretin and fumaric acid esters for psoriasis: Does treatment history matter?.

The risk of melanoma in patients with immune-mediated inflammatory diseases exposed to biological therapies: systematic review and meta-analysis (2019)
Presentation / Conference
Esse, S., Mason, K. J., Green, A. C., & Warren, R. B. (2019, July). The risk of melanoma in patients with immune-mediated inflammatory diseases exposed to biological therapies: systematic review and meta-analysis. Poster presented at BRITISH ASSOCIATION OF DERMATOLOGISTS 99TH ANNUAL MEETING, LIVERPOOL, U.K

Biological therapies are used in the treatment of immunemediated inflammatory diseases (IMIDs), including moderateto-severe psoriasis, rheumatoid arthritis (RA), psoriatic arthritis (PsA) and inflammatory bowel disease (IBD). Melanoma is a highly i... Read More about The risk of melanoma in patients with immune-mediated inflammatory diseases exposed to biological therapies: systematic review and meta-analysis.